Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBT and Escitalopram Augmentation for GAD
NCT00219349Phase 4Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Jan 2005
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of escitalopram in generalized anxiety disorder (GAD), sponsored by New York State Psychiatric Institute. Started Jan 2005; status: completed.
02
Drugs
escitalopram
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT00219349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00219349.